Login / Signup

A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach.

Michal HaranVita MirkinAndrei BraesterNurith HarpazOlga ShevetzMarina ShtreiterShulamit GreenbergOrly MordichOrna AmramInbal Binsky-EhrenreichAyelet MaromIdit ShacharYair HerishanuRosa RuchlemerAlain BerrebiLiora ValinskyMordechai ShtalridLev Shvidel
Published in: British journal of haematology (2017)
Keyphrases
  • monoclonal antibody
  • clinical trial
  • case report
  • phase ii
  • double blind
  • nk cells
  • phase iii
  • drug induced
  • placebo controlled